Vigil Neuroscience, Inc. (VIGL) Financials
Stock symbol VIGL is outdated, potentially delisted? Maybe it is available on other exchange?
VIGL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 159.2 million | 23.3 million |
| June 30, 2023 | 175.4 million | 21.6 million |
| March 31, 2023 | 192.4 million | 21.0 million |
| Dec. 31, 2022 | 200.4 million | 11.3 million |
VIGL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -17.4 million | 2.4 million |
| June 30, 2023 | -15.5 million | 2.3 million |
| March 31, 2023 | -22.7 million | 1.7 million |
| Dec. 31, 2022 | -17.4 million | 1.5 million |
VIGL Net Income
No data available :(
VIGL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 164.5 million | - | 14.1 million |
| June 30, 2023 | 150.2 million | - | 14.2 million |
| March 31, 2023 | 164.5 million | - | 14.7 million |
| Dec. 31, 2022 | 186.6 million | - | 176000 |
VIGL Shares Outstanding
VIGL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 47000 | 15.4 million | 6.9 million | - |
| June 30, 2023 | 122000 | 14.9 million | 7.0 million | - |
| March 31, 2023 | 492000 | 13.8 million | 6.9 million | - |
| Dec. 31, 2022 | 272000 | 12.2 million | 6.7 million | - |
VIGL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 110000 |
| June 30, 2023 | - | 474000 |
| March 31, 2023 | - | 383000 |
| Dec. 31, 2022 | - | 274000 |
VIGL
Price: $8.05
52 week price:
Earnings Per Share: -2.06 USD
P/E Ratio: -3.91
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 7969
Market Capitalization: 383.9 million